Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.21.2
Stock-Based Compensation
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation

10. Stock-Based Compensation

 

A summary of the Company’s outstanding stock option activity for the nine months ended September 30, 2021 and 2020 is as follows:

 

          September 30, 2021        
    Options     Weighted- Average Exercise Price    

Weighted-

Average

Remaining

Contractual Life

(Years)

   

Intrinsic

Value

 
As of December 31, 2020     465,393     $ 5.53       9.3       - $  
Granted     368,500       1.93       10.0       -  
Exercised     -       -       -       -  
Forfeited     -       -       -       -  
Expired     -       -       -       -  
As of September 30, 2021     833,893     $ 3.98       8.9     $ 417,164  
Exercisable at September 30, 2021     221,834     $ 12.26       8.6     $ -  
Vested and expected to vest at September 30, 2021     833,893     $ 3.98       8.9     $ 417,164  

 

          September 30, 2020        
    Options     Weighted- Average
Exercise Price
    Weighted-Average Remaining Contractual
Life
(Years)
    Intrinsic Value  
As of December 31, 2019     377     $ 7,446.69       5.3     $ -  
Granted     465,017       0.47       10.0       -  
Exercised     -       -       -       -  
Forfeited     -       -       -       -  
Expired     -       -       -       -  
As of September 30, 2020     465,394     $ 5.90       9.6     $ 746,774  
Exercisable and vested at September 30, 2020     377     $ 7,446.69       4.6     $ -  

 

The Company estimates the fair value of each stock option on the grant date using the Black-Scholes-Merton valuation model, which requires several estimates including an estimate of the fair value of the underlying common stock on grant date. The expected volatility was based on an average of the historical volatility of the Company. The expected term was contractual life of option. The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option. The following weighted average assumptions were used in the calculation to estimate the fair value of options granted to employees and non-employees during the nine months ended September 30, 2021. During the nine months ended September 30, 2021 the Company granted stock options with an estimated fair value of approximately $0.6 million.

    September 30, 2021   
Weighted-average risk-free interest rate     0.73%-0.85 %
Weighted-average expected life (in years)     5.3-5.9  
Expected dividend yield     - %
Weighted-average expected volatility     138%-139 %

 

Of the 368,500 options granted during the nine months ended September 30, 2021, 60,000 were to non-executive members of the board of directors. Of the 833,893 options outstanding as of September 30, 2021, 295,000 were awarded to non-executive members of the board of directors. 

 

Unrecognized stock-based compensation as of September 30, 2021, is as follows (in thousands):

 

          Weighted Average  
    Unrecognized Stock-Based     Remaining
of Recognition
 
    Compensation     (in years)  
Stock options   $ 622       2.1  
Stock grants   $ 14       1.6